In patients who received irradiation, insulin-induced hypoglycemia may be the most sensitive and reliable pharmacologic test of GH status, however because it carries the risk of serious hypoglycemia-related events, it should be performed only in experienced clinics under close surveillance. The gene discussed is INS; the disease is Hypoglycemia.